Atrás
Rango del Día
$28.99
$30.65
Rango de 52 Semanas
$14.06
$42.00
Volumen
632,741
Promedio 50D / 200D
$32.70
/
$29.92
Cierre Anterior
$30.01
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -17.0 | 0.3 |
| P/B | 5.1 | 2.9 |
| ROE % | -28.3 | 3.7 |
| Net Margin % | -905.7 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$47.20
+57.0%
Low: $37.00
High: $55.00
EPS Futuro
-$1.91
Ingresos Est.
28 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$3.66
-$0.01 – $13.82
|
1.3 B | 6 |
| FY2029 |
$1.59
$0.00 – $6.00
|
830 M | 6 |
| FY2028 |
-$0.21
-$0.81 – $0.00
|
430 M | 7 |
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -148.03M
PEG of 0.62 suggests growth is underpriced
Capital efficient — spends only 1.09% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)-50.61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-28.29%
ROIC-24.76%
Net Margin-905.74%
Op. Margin-1002.90%
Seguridad
Debt / Equity
0.00
Current Ratio7.88
Interest Coverage0.00
Valoración
P/E Ratio
-16.96
P/B Ratio5.06
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -50.61% | Revenue Growth (3Y) | 26.38% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 22.50M | Net Income (TTM) | -203.82M |
| ROE | -28.29% | ROA | -26.49% |
| Gross Margin | 99.74% | Operating Margin | -1002.90% |
| Net Margin | -905.74% | Free Cash Flow (TTM) | -148.03M |
| ROIC | -24.76% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 7.88 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -16.96 | P/B Ratio | 5.06 |
| P/S Ratio | 153.59 | PEG Ratio | 0.62 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.46B | Enterprise Value | 2.97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 22.50M | 45.56M | 14.09M | 102.69M | 0.0 |
| Net Income | -203.82M | -241.60M | -176.94M | -22.63M | -41.79M |
| EPS (Diluted) | -1.75 | -2.56 | -2.15 | -1.19 | -3.34 |
| Gross Profit | 22.44M | 45.56M | 14.09M | 102.69M | 0.0 |
| Operating Income | -225.68M | -176.29M | -182.97M | -3.56M | -34.98M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 769.28M | 864.62M | 347.10M | 478.50M | 67.99M |
| Total Liabilities | 85.85M | 107.12M | 58.70M | 48.43M | 11.36M |
| Shareholders' Equity | 683.43M | 757.50M | 288.39M | 430.07M | 56.63M |
| Total Debt | 202,000.0 | 448,000.0 | 60,000.0 | 126,000.0 | 186,511.0 |
| Cash & Equivalents | 490.00M | 771.74M | 340.45M | 467.73M | 60.38M |
| Current Assets | 675.70M | 863.41M | 346.79M | 477.98M | 66.96M |
| Current Liabilities | 85.79M | 106.92M | 49.90M | 36.06M | 11.24M |